U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06837480) titled 'Phase II RCT of Photobiomodulation in Head and Neck Chronic Lymphedema' on Feb. 15.
Brief Summary: The U.S. Food and Drug Administration approved photobiomodulation therapy (PBMT) as a treatment for breast cancer-related arm lymphedema (BCRL) in 2006. We conducted two pilot clinical trials. Results demonstrated the feasibility, acceptability, and preliminary efficacy of PBMT for the treatment of chronic lymphedema in head and neck cancer (HNC) survivors. The objective of this study is to further investigate and confirm the positive effects of PBMT on HNC-related chronic lymphedema.
Study Start Date: March 15
Study Type: INTERVENTI...